The results of your word search

Takara Bio Initiates Phase 1 HIV Gene Therapy Clinical Trial (Jan 7, 2013)

Takara Bio Submits IND Application for HIV-1 Gene Therapy to the FDA (Mar 23, 2012)

Takara Bio and Tianjin Medical University in Gene Therapy Project (Aug 3, 2011)

Takara Bio RetroNectin to UCLA for TCR-gene Therapy Clinical Trials in Advanced Melanoma (Dec 18, 2008)

ViroMed Obtains Clinical Trial Approval of Gene Therapy Treatment for Chronic Granulomatosis (Jan 11, 2007)

Takara Bio's RetroNect Used in Australia for Gene Therapy Clinical Trials of Multiple Myeloma (Dec 18, 2006)

Takara Bio Offers Drug for Treatment of Chronic Lymphatic Leukemia (Sept 7, 2006)

Takara Bio Licenses FLT3 Gene Mutation Detection Method to InVivoScribe Technologies (July 12, 2006)

Takara Bio, Okayama University Jointly Confirm That Angelica Utilis Promotes Bone Formation and Increases Bone Mass (July 4, 2006)

Takara Bio, Chinese CDC to Collaborate in AIDS Research (June 20, 2006)

Takara Bio Announces Start of Clinical Research of Cancer Immunotherapy using RetroNectin(R) Expansion Culture System at Tianjin Cancer Institute & Hospital, China (May 2, 2008)

Takara Bio Grants Transgenomic License for LA-PCR Technology (May 7, 2007)

Takara Bio Will Release FLT3/ITD Mutation Detection Set for Refractory Leukemia (Jan 30, 2003)

Takara Bio Inc. Successfully Develops 'Takara-Hubble Slide' for DNA Microarray Production (Aug 29, 2002)

Takara Bio to Produce DNA Fragments for DNA Microarrays on Industrial Scale (May 7, 2002)

Takara Bio Sets Up Organic Produce AgriBIO Operation on Yakushima Island to Develop Health Foods (Apr 17, 2002)

Takara Bio To Provide Unique Mushrooms to South Korean Consumers Through Pulmuone Joint-Venture (Apr 8, 2002)